WikiPathway enrichment analysis suggested that VAV3 negatively regulates pathways related to the ubiquitin–proteasome system, extracellular matrix and membrane receptors, inflammatory response, matrix metalloproteinases, and cell cycle (Figure 3D), which indicate a protective role of VAV3 against RCC. The gene discussed is VAV3; the disease is renal cell carcinoma.